• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗对慢性完全性冠状动脉闭塞疗效的荟萃分析。

Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.

作者信息

Li Ruogu, Yang Shuansuo, Tang Lei, Yang Yiqing, Chen Hui, Guan Shaofeng, Han Wenzheng, Liu Hua, Dai Jinjie, Gan Qian, Fang Weiyi, Qu Xinkai

机构信息

Department of Cardiology, Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University, NO,241, Huaihai Xi Road, Xuhui District, Shanghai 200030, China.

出版信息

J Cardiothorac Surg. 2014 Feb 28;9:41. doi: 10.1186/1749-8090-9-41.

DOI:10.1186/1749-8090-9-41
PMID:24580774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3974033/
Abstract

BACKGROUND AND PURPOSE

Coronary chronic total occlusion (CTO) is the last stage of coronary artery atherosclerosis. Percutaneous coronary intervention (PCI) is a therapeutic procedure used to recanalize vessels with total occlusion. However, successful recanalization of CTO is still not optimal, and the key influence factors are still uncertainty. Therefore, a scientific evaluation on the effective of PCI for CTO treatment is necessary.

METHODS

Relevant studies of PCI treatment for CTO were examined. Data were extracted and assessed by two independent clinical experts. Embase, PubMed and Medline et al. were used as database. The main research key words include "CTO", "PCI", "Stent", "Reopen", "long-term", "follow-up" and "outcome". Quality assessment was carried out according to the Cochrane Handbook. The selected data were pooled and analyzed using fixed-effect model and random-effect model. Heterogeneity was assessed using the I(2) test, Q test, L'abbe and Galbraith. Comprehensive Meta -Analysis 2.0 and Metanalysis 1.0 were used for statistics analysis in this research.

RESULTS

A total of 16 articles involving 6695 cases in successful CTO recanalization (CTO success group) and 2370 cases in failed CTO recanalization(CTO failure group) were included in this research. Low CTO success was associated with elder age, previous coronary artery bypass graft surgery (CABG) history, multi-vessel diseases and right coronary artery disease lesion. Six follow-up variables including major adverse cardiac events (MACE), recurrent myocardial infarction (MI), all-cause death, incidence of angina, subsequent CABG and cumulative survival rate were found significantly reduced associated with CTO success.

CONCLUSIONS

Clinical baseline characteristics such as age, previous CABG history and lesion baseline characteristics such as lesion length, multi-vessel diseases might be important factors influencing the successful rate of CTO recanalization. Compared to CTO failure patients, all six follow-up variables showed advantage for CTO success patients.

摘要

背景与目的

冠状动脉慢性完全闭塞(CTO)是冠状动脉粥样硬化的终末阶段。经皮冠状动脉介入治疗(PCI)是用于使完全闭塞血管再通的一种治疗手段。然而,CTO的成功再通仍不理想,关键影响因素尚不明确。因此,有必要对PCI治疗CTO的有效性进行科学评估。

方法

检索关于CTO的PCI治疗的相关研究。由两名独立的临床专家提取并评估数据。使用Embase、PubMed和Medline等作为数据库。主要研究关键词包括“CTO”“PCI”“支架”“再通”“长期”“随访”和“结局”。根据Cochrane手册进行质量评估。使用固定效应模型和随机效应模型对所选数据进行汇总和分析。使用I(2)检验、Q检验、L'abbe和Galbraith评估异质性。本研究使用Comprehensive Meta -Analysis 2.0和Metanalysis 1.0进行统计分析。

结果

本研究共纳入16篇文章,其中成功实现CTO再通的有6695例(CTO成功组),CTO再通失败的有2370例(CTO失败组)。CTO成功率低与高龄、既往冠状动脉旁路移植术(CABG)史、多支血管病变和右冠状动脉病变相关。发现包括主要不良心脏事件(MACE)、再发心肌梗死(MI)、全因死亡、心绞痛发生率、后续CABG和累积生存率在内的六个随访变量与CTO成功显著降低相关。

结论

年龄、既往CABG史等临床基线特征以及病变长度、多支血管病变等病变基线特征可能是影响CTO再通成功率的重要因素。与CTO失败患者相比,六个随访变量对CTO成功患者均显示出优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/21c689955a7a/1749-8090-9-41-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/e5db75004f1a/1749-8090-9-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/f3fa46e8c506/1749-8090-9-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/1fbad8997067/1749-8090-9-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/8b0f4362e999/1749-8090-9-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/555837f840c4/1749-8090-9-41-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/e2687fb33ecc/1749-8090-9-41-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/c6cd617c2de3/1749-8090-9-41-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/77e7f63db310/1749-8090-9-41-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/ae528cf3f79e/1749-8090-9-41-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/21c689955a7a/1749-8090-9-41-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/e5db75004f1a/1749-8090-9-41-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/f3fa46e8c506/1749-8090-9-41-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/1fbad8997067/1749-8090-9-41-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/8b0f4362e999/1749-8090-9-41-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/555837f840c4/1749-8090-9-41-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/e2687fb33ecc/1749-8090-9-41-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/c6cd617c2de3/1749-8090-9-41-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/77e7f63db310/1749-8090-9-41-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/ae528cf3f79e/1749-8090-9-41-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86e1/3974033/21c689955a7a/1749-8090-9-41-10.jpg

相似文献

1
Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.经皮冠状动脉介入治疗对慢性完全性冠状动脉闭塞疗效的荟萃分析。
J Cardiothorac Surg. 2014 Feb 28;9:41. doi: 10.1186/1749-8090-9-41.
2
Recanalization of Chronic Total Occlusions in Patients With Previous Coronary Bypass Surgery and Consideration of Retrograde Access via Saphenous Vein Grafts.既往接受冠状动脉搭桥手术患者慢性完全闭塞病变的再通及经大隐静脉桥逆行入路的考量
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003515.
3
Long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion.经皮冠状动脉介入治疗支架内慢性完全闭塞的长期结果。
Chin Med J (Engl). 2020 Dec 16;134(3):302-308. doi: 10.1097/CM9.0000000000001289.
4
Long-Term Outcomes of Chronic Total Occlusion Recanalization Versus Percutaneous Coronary Intervention for Complex Non-Occlusive Coronary Artery Disease.慢性完全闭塞血管再通与经皮冠状动脉介入治疗复杂非闭塞性冠状动脉疾病的长期结局比较。
Am J Cardiol. 2020 Jan 15;125(2):182-188. doi: 10.1016/j.amjcard.2019.10.034. Epub 2019 Nov 5.
5
Lesion characteristics and procedural complications of chronic total occlusion percutaneous coronary intervention in patients with prior bypass surgery: A meta-analysis.既往旁路移植术后患者慢性完全闭塞经皮冠状动脉介入治疗的病变特征和操作并发症:一项荟萃分析。
Clin Cardiol. 2022 Jan;45(1):18-30. doi: 10.1002/clc.23766. Epub 2022 Jan 6.
6
Improved cardiac survival, freedom from MACE and angina-related quality of life after successful percutaneous recanalization of coronary artery chronic total occlusions.经皮冠状动脉慢性完全闭塞血管再通治疗后,心脏存活率提高,主要不良心血管事件和心绞痛相关生活质量改善。
Int J Cardiol. 2012 Nov 1;161(1):31-8. doi: 10.1016/j.ijcard.2011.04.023. Epub 2011 Jul 1.
7
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes.成功的慢性完全闭塞经皮冠状动脉介入治疗对后续临床结局的影响。
J Invasive Cardiol. 2020 Nov;32(11):433-439. Epub 2020 Jun 22.
8
The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.真实世界中成功的慢性完全闭塞经皮冠状动脉介入治疗对长期临床结局的影响。
BMC Cardiovasc Disord. 2021 Apr 15;21(1):182. doi: 10.1186/s12872-021-01976-w.
9
Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.经皮冠状动脉介入治疗支架内再狭窄慢性完全闭塞病变的 30 天和 5 年结果:来自 2659 例连续患者的数据。
Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:1016-1024. doi: 10.1002/ccd.29585. Epub 2021 Mar 5.
10
Meta-analysis of the long term effects of different interventions on chronic total coronary occlusions.不同干预措施对慢性完全性冠状动脉闭塞的长期效果的荟萃分析。
Eur Rev Med Pharmacol Sci. 2013 Jun;17(12):1583-9.

引用本文的文献

1
The role of chronic total occlusions in non-infarct-related arteries in acute coronary syndrome patients: a systematic review.急性冠状动脉综合征患者非梗死相关动脉中慢性完全闭塞的作用:系统评价。
Future Cardiol. 2024;20(10):581-590. doi: 10.1080/14796678.2024.2406651. Epub 2024 Oct 9.
2
Successful revascularization of right coronary artery chronic total occlusion by the antegrade and retrograde approaches.经正向和逆向途径成功实现右冠状动脉慢性完全闭塞病变的血管再通。
AME Case Rep. 2019 Aug 8;3:30. doi: 10.21037/acr.2019.06.01. eCollection 2019.
3
Impact of chronic total occlusion lesion length on six-month angiographic and 2-year clinical outcomes.

本文引用的文献

1
Impact of residual chronic total occlusion of right coronary artery on the long-term outcome in patients treated for unprotected left main disease: the Milan and New-Tokyo registry.右冠状动脉慢性完全闭塞对非保护左主干病变治疗患者长期预后的影响:米兰和新东京注册研究。
Circ Cardiovasc Interv. 2013 Apr;6(2):154-60. doi: 10.1161/CIRCINTERVENTIONS.112.000079. Epub 2013 Apr 9.
2
Management of chronic total occlusion by percutaneous coronary intervention.经皮冠状动脉介入治疗慢性完全闭塞病变的管理
Heart. 2012 May;98(10):822-8. doi: 10.1136/heartjnl-2011-300616.
3
Surgery for chronic total occlusion of the left main coronary artery.
慢性完全闭塞病变长度对 6 个月血管造影和 2 年临床结果的影响。
PLoS One. 2018 Nov 13;13(11):e0198571. doi: 10.1371/journal.pone.0198571. eCollection 2018.
4
Influence of chronic kidney disease on the outcome of patients with chronic total occlusion.慢性肾脏病对慢性完全闭塞患者预后的影响。
Am J Transl Res. 2016 Jan 15;8(1):196-208. eCollection 2016.
5
The impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcomes.慢性完全闭塞病变经皮冠状动脉介入治疗对左心室功能及临床结局的影响。
J Thorac Dis. 2015 Jul;7(7):1107-10. doi: 10.3978/j.issn.2072-1439.2015.07.24.
6
Retraction note: Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.撤稿说明:经皮冠状动脉介入治疗对慢性完全性冠状动脉闭塞影响的荟萃分析。
J Cardiothorac Surg. 2015 Mar 27;10:43. doi: 10.1186/s13019-015-0235-8.
7
Myocardial viability in coronary artery chronic total occlusion.冠状动脉慢性完全闭塞时的心肌存活情况
Curr Cardiol Rep. 2015 Jan;17(1):552. doi: 10.1007/s11886-014-0552-x.
左主干冠状动脉慢性完全闭塞的外科手术
Ann Saudi Med. 2012 Mar-Apr;32(2):156-61. doi: 10.5144/0256-4947.2012.156.
4
Current percutaneous recanalization of coronary chronic total occlusion.当前冠状动脉慢性完全闭塞病变的经皮再通治疗
Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):265-77. doi: 10.1016/j.recesp.2011.10.026. Epub 2012 Feb 3.
5
CT coronary angiography-guided percutaneous coronary intervention for chronic total occlusion combined with retrograde approach.CT冠状动脉造影引导下经皮冠状动脉介入治疗慢性完全闭塞病变并联合逆行途径
J Invasive Cardiol. 2012 Jan;24(1):E5-9.
6
Chronic total coronary occlusion percutaneous intervention the case for randomized trials.慢性冠状动脉完全闭塞的经皮介入治疗:随机试验的必要性
JACC Cardiovasc Interv. 2011 Sep;4(9):962-4. doi: 10.1016/j.jcin.2011.05.023.
7
Contemporary principles of coronary chronic total occlusion recanalization.当代冠状动脉慢性完全闭塞再通的原则。
Catheter Cardiovasc Interv. 2010 Mar 1;75 Suppl 1:S21-7. doi: 10.1002/ccd.22382.
8
Clinical outcomes of percutaneous coronary intervention for chronic total occlusion lesions in remote hospitals without on-site surgical support.偏远医院无现场外科支持下行经皮冠状动脉介入治疗慢性完全闭塞病变的临床结局。
Chin Med J (Engl). 2009 Oct 5;122(19):2278-85.
9
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention.评价原发性经皮冠状动脉介入治疗后并发慢性完全闭塞对长期死亡率和左心室功能的影响。
JACC Cardiovasc Interv. 2009 Nov;2(11):1128-34. doi: 10.1016/j.jcin.2009.08.024.
10
Chronic total occlusion angioplasty in the United States.美国的慢性完全闭塞性血管成形术
JACC Cardiovasc Interv. 2009 Jun;2(6):479-86. doi: 10.1016/j.jcin.2009.02.008.